Strategy
Vectura's goal is to be a cash-generating business that creates value for its stakeholders. To achieve this goal, Vectura is:
- Developing pulmonary products using its proprietary inhaler
device and formulation technologies, expertise and know-how to
advance programmes to clinical proof-of-concept, and
- for selected products in respiratory and neurological illness, Vectura plans to further develop/co-develop in-house to regulatory approval in order to capture maximum value for the Company and its shareholders
- for the products that address larger markets, Vectura will out-license the products to major pharmaceutical companies that have appropriate financial resources and existing sales and marketing infrastructures, with Vectura’s return being milestones and royalties
- Entering into a number of technology collaborations with pharmaceutical company partners to exploit both the generic and branded markets for the joint development of high-value pulmonary product opportunities, and
- Continuing to build its pulmonary franchise through internal innovation as well as exploring opportunities for the acquisition of products, technologies or businesses that support these goals.
